Lupin launches Bromfenac Ophthalmic Resolution, 0.075 per cent – ET HealthWorld | Pharma

0
3


Bromfenac Ophthalmic Resolution, 0.075 per cent is the generic equal of BromSite Ophthalmic Resolution, 0.075 per cent, of Solar Pharmaceutical Industries Restricted. It’s indicated for the therapy of postoperative irritation and the prevention of ocular ache in sufferers present process cataract surgical procedure.

  • Up to date On Feb 13, 2024 at 05:31 PM IST

Mumbai: Lupin Restricted introduced the launch of Bromfenac Ophthalmic Solution, 0.075 per cent, after receiving approval from the United States Food and Drug Administration (US FDA).

Bromfenac Ophthalmic Resolution, 0.075 per cent is the generic equal of BromSite Ophthalmic Solution, 0.075 per cent, of Sun Pharmaceutical Industries Limited. It’s indicated for the therapy of postoperative irritation and the prevention of ocular ache in sufferers present process cataract surgical procedure.

Bromfenac Ophthalmic Resolution 0.075 per cent (RLD BromSite) had estimated annual gross sales of $15 million within the US (IQVIA MAT December 2023).

  • Printed On Feb 13, 2024 at 05:31 PM IST

Be a part of the neighborhood of 2M+ trade professionals

Subscribe to our e-newsletter to get newest insights & evaluation.

Obtain ETHealthworld App

  • Get Realtime updates
  • Save your favorite articles


Scan to obtain App




Source link

Previous articleImportant Make-up Merchandise: 5 make-up merchandise you have to have always in your bag
Next articleLal Salaam Field Workplace Assortment Day 5: Film earnings proceed to fall | Leisure Information – Enterprise Commonplace

LEAVE A REPLY

Please enter your comment!
Please enter your name here